new indications for glp-1 drugs The Weight Management Meds GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
This artificial sweetener may negatively impact the gut microbiome, though research is mixed
Eli Lilly's Employer Push Could Unlock New GLP-1 Demand This would not only enhance its access to China's growing weight-loss market but also shore up global supply
GP: Writing review & editing
J Clin Endocrinol Metab (2008) 93(7):26708
To help the body adjust and reduce side effects, treatment usually begins with a low dose that is gradually increased over several weeks until the maintenance dose is reached
The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system
